ACTIVE SUBSTANCE / INN

SARILUMAB

Brand name(s): Kevzara, KEVZARA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Arthritis, Rheumatoid
BLA761037
ACTIVE SUBSTANCE
Sarilumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Sanofi Winthrop Industrie, SANOFI SYNTHELABO
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KEVZARABLA761037SANOFI SYNTHELABOPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KevzaraSanofi Winthrop IndustrieAuthorised23/06/2017Arthritis, Rheumatoid

FULL INTELLIGENCE ON SARILUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →